CMG Pharmaceutical Co., Ltd. (058820.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap274.69B
Enterprise Value340.58B
P/E Ratio15.31
PEG Ratio0.04
Price/Sales Ratio0.77
Price/Book Ratio0.43
Enterprise/Revenue1.26
Enterprise/EBITDA34.76

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.05
Operating Margin-0.03
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue105.23B
Revenue/Share782.31
Gross Profit59.45B
EBITDA-610.42M
Net Income-8.96B
Diluted EPS-60.63

Balance Sheet

Total Cash17.75B
Total Cash/Share119.98
Total Debt68.7B
Total Debt/Equity0.34
Current Ratio1.17
Book Value Per Share1,381.28

Price History

52-Week Change-68.91
52-Week High2,205
52-Week Low526
Moving Average 50 Days713.84
Moving Average 200 Days1,453.21

Statistics

Average Volume1.01M
Shares Outstanding147.84M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateOctober 27, 2026
AD